OP015 Multicentre clinical trial with topical administration of the Toll-Like receptor 9 agonist DIMS0150 shows evidence for eff
![Journal of Crohn's and Colitis | Abstracts of the 8th Congress of ECCO – the European Crohn's and Colitis Organisation | ScienceDirect.com by Elsevier Journal of Crohn's and Colitis | Abstracts of the 8th Congress of ECCO – the European Crohn's and Colitis Organisation | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S1873994613X00030-cov200h.gif)
Journal of Crohn's and Colitis | Abstracts of the 8th Congress of ECCO – the European Crohn's and Colitis Organisation | ScienceDirect.com by Elsevier
![Cromos™ Pharma at European Cancer Congress 2013 (ECCO-ESMO-ESTRO) in Amsterdam, The Netherlands on 27 September – 01 October 2013 | Cromos Pharma Cromos™ Pharma at European Cancer Congress 2013 (ECCO-ESMO-ESTRO) in Amsterdam, The Netherlands on 27 September – 01 October 2013 | Cromos Pharma](https://www.cromospharma.com/wp-content/uploads/2021/11/0862ddb46ad00030a388900b30acc69a.png)